Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI watches embryo movies to predict IVF success

NCT ID NCT07611448

Knowledge-focused Sponsor: Viable Biosciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study records 30-second videos of embryos from 1,000 IVF patients and uses artificial intelligence to analyze their movement patterns. The goal is to see if these patterns can predict whether an embryo will lead to a successful pregnancy. Participants receive standard care and no direct benefit from the recordings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will enroll patients undergoing ART who generate at least one blastocyst on day 5, 6, or 7 of in-vitro culture. All participants will receive clinical management according to the treating physician's judgment and the established clinical and laboratory protocols of the IVF center. Participation in this observational study will not modify medical treatment, laboratory procedures, or clinical decision-making, and no additional interventions affecting patient care will be introduced. Eligibility for study participation requires a thirty-second real-time video recording. Blastocysts recorded may originate from conventional IVF or ICSI cycles, frozen-thawed embryo transfers, or embryos undergoing biopsy for PGT-A. Each recorded embryo will be appropriately coded to document developmental stage, embryo status (fresh or frozen-thawed), and genetic testing classification when available, including chromosomal designation and reported sex determination where applicable.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed Inform Consent * Ages between 18 and 45 years * Patients using own or donated eggs * Patients undergoing assisted reproduction procedures (ICSI with Embryo Transfer, Frozen Embryo Transfers with or without PGT-A receiving a single embryo transfer. * Patients with at least one embryo at the blastocyst stage on day 5, day 6 or day 7 of embryo development. * Patients using a surrogate carrier for the embryo transfer procedure. * Patients with Abnormal Embryos after PGT-A to be discarded. * Patients with Euploid Embryos after PGT-A to be discarded Exclusion Criteria: * Absence of viable embryos at the blastocyst stage. * Any uterine abnormalities that could affect embryo implantation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infertility (ivf patients) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infertility (ivf patients) Infertility assisted reproductive technology

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Women's Specialty & Fertility Center

    Clovis, California, 93611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.